Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q2 2023 Earnings Presentation
9 slides from Phibro Animal Health's earnings presentation, Feb 9, 2023
Slide 1: Phibro Animal Health Corporation Webcast and Conference Call
Phibro Animal Health Corporation Webcast and Conference Call February 9, 2023 Financial Results U.S. toll-free +1.888.330.2022 Fiscal Year 2023 International toll +1.365.977.0051 Second Quarter Ended December 31, 2022 Conference ID: [3927884] 1 February 9, 2023 Webcast & Conference Call
Slide 2: Important Information
Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to future debt and leverage levels. All statements other than statements of historical or current
Slide 3: Key Themes
Key Themes Second Quarter Sales growth of 5%, driven Companion animal Global economy showing We are reiterating our by our domestic Animal experience added to signs of improvement, but guidance for Net Sales & Health business Board of Directors still a challenge Adjusted EBITDA Year-over-year net sa
Slide 4: Financial Performance - Consolidated
Financial Performance - Consolidated Second Quarter, Year-on-Year comparison $ in millions, except per share data Net Sales – increased $11.9 million, or 5%, driven by YOY improvement in both the Animal Health and Performance Product segments, offset by a decline in the Mineral Nutrition Q2 %∆ seg
Slide 5: Financial Performance – Animal Health
Financial Performance – Animal Health Second Quarter, Year-on-Year comparison $ in millions Net Sales – increased $12.9 million, or 9% YOY MFAs and other Q2 %∆ - Increased $5.5 million, or 6%, due to increased demand for MFAs in Latin America and processing Animal Health aids used in the ethanol
Slide 6: Financial Performance – Other Segments
Financial Performance – Other Segments Second Quarter, Year-on-Year comparison $ in millions YOY Mineral Nutrition Q2 %∆ - Net sales decreased $5.0 million, or 8%, primarily due to a Mineral Nutrition decrease in demand for trace minerals, partially offset by higher selling prices which is correla
Slide 7: Key Capitalization Metrics
Key Capitalization Metrics Second Quarter Highlights $m 1 -$45 million of trailing 12-month free cash flow; Free Cash Flow operating cash flow of -$5 million less capital expenditures of $40 million1 $202 million; $78 million of cash and short-term Liquidity investments + $124 million of available r
Slide 8: Financial Guidance
Financial Guidance Fiscal Year 2023 $ in millions, except earnings per share (EPS) data The Company reiterated guidance for Net Sales, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS and Adjusted Effective Tax Rate. We are lowering guidance for GAAP Net Income and GAAP Diluted EPS to
Slide 9: © 2023 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy
© 2023 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that